Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Talking it out: psychotherapy shows promise for depressed breast cancer patients

NCT ID NCT06546787

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether interpersonal psychotherapy (a type of talk therapy) could help breast cancer patients who are at risk for depression. Forty-two patients with stage II or III breast cancer took part. The therapy aimed to lower depression scores and improve how patients manage emotions and feel supported by others. Results are expected to show whether this approach can be a helpful addition to cancer care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
interpersonal psychotherapy (talk therapy)
What this could lead to
If effective, this therapy could offer a non-drug way to ease depression and boost emotional well-being in breast cancer patients.
What could go wrong
This is a small, completed study with only 42 participants, so results may not apply to all patients. The therapy requires time and internet access, which may limit its use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Aug 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Includes Criteria * Ability to communicate in Turkish * Diagnosed with Stage-II and Stage-III breast cancer * Continuing outpatient treatment * Four points on the Primary Care Depression Screening Scale * Internet connection * Has a phone that can use the zoom app to continue conversations to be * To be able to use the Zoom app Exclusion Criteria * Being a pediatric oncology/hematology patient * Diagnosed with stage -IV breast cancer * Taking psychopharmacological medication * To have received KIPT within the last year

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer patients diagnosed are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Koc University

    Istanbul, Nursing Department, 34020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.